Zhejiang Hisoar Chuannan Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and 5 valid CEPs across a filed portfolio of 7 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 31 October 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Taizhou City, China | Not on file |
| Taizhou, China | Not on file |
| China, China | 3006545436 |
| Molecule | Regulators | Docs |
|---|---|---|
| Phenylephrine | SFDA (Saudi Arabia) | 2 |
| Avibactam | US FDA | 1 |
| Clindamycin Hydrochloride | EDQM | 1 |
| Clindamycin Phosphate | EDQM | 1 |
| Metoprolol | EDQM | 1 |
| Quetiapine | EDQM | 1 |
| Repaglinide | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| EMA | None | 1 |
Choose your molecules and target markets. Zhejiang Hisoar Chuannan Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free